Cargando…
Amelioration of Cognitive Dysfunction in APP/PS1 Double Transgenic Mice by Long-Term Treatment of 4-O-Methylhonokiol
Alzheimer’s disease (AD) is the most common neurodegenerative disease without known ways to cure. A key neuropathologic manifestation of the disease is extracellular deposition of beta-amyloid peptide (Aβ). Specific mechanisms underlying the development of the disease have not yet been fully underst...
Autores principales: | Jung, Yu-Yeon, Lee, Young-Jung, Choi, Dong-Young, Hong, Jin Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060074/ https://www.ncbi.nlm.nih.gov/pubmed/25009704 http://dx.doi.org/10.4062/biomolther.2014.030 |
Ejemplares similares
-
Alleviation of Kainic Acid-Induced Brain Barrier Dysfunction by 4-O-Methylhonokiol in In Vitro and In Vivo Models
por: Han, Jin-Yi, et al.
Publicado: (2015) -
Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
por: Yang, Wenjuan, et al.
Publicado: (2018) -
Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity
por: Lee, Yong Kyung, et al.
Publicado: (2009) -
4-O-Methylhonokiol Influences Normal Cardiovascular Development in Medaka Embryo
por: Singha, Santu K., et al.
Publicado: (2019) -
Ligustilide Ameliorates Memory Deficiency in APP/PS1 Transgenic Mice via Restoring Mitochondrial Dysfunction
por: Xu, Yi-Jun, et al.
Publicado: (2018)